Eikon Therapeutics, Inc. Common Stock (EIKN) vs YD Bio Limited Ordinary Shares (YDES)

A side-by-side comparison of Eikon Therapeutics, Inc. Common Stock and YD Bio Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Eikon Therapeutics, Inc. Common Stock logo
EIKN
Eikon Therapeutics, Inc. Common Stock
$407M
$7.51HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
YD Bio Limited Ordinary Shares logo
YDES
YD Bio Limited Ordinary Shares
$436M
$6.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — EIKN vs YDES

growth of $100 · dividends reinvested · last 1y
EIKN -49.7% (-49.7%/yr)YDES -33.9% (-33.9%/yr)YDES compounded faster over this window
20406080100Start $100$50$66
EIKN YDES

EIKN vs YDES: by the numbers

  • •YDES is the larger company ($436M vs $407M market cap).
  • •Both run net losses; EIKN's is the smaller (0.00% vs -1392.61% net margin).

Metrics side by side

Valuation

MetricEIKNYDES
P/B ratio0.87N/A

Profitability

MetricEIKNYDES
Gross margin0.00%-7.06%
Operating margin0.00%-883.31%
Net margin0.00%-1392.61%
ROE-69.06%-66.49%
ROIC-46.16%N/A

Go deeper

Full EIKN analysisFull YDES analysisInteractive comparison tool

Dig into the metrics

Eikon Therapeutics, Inc. Common Stock ROEYD Bio Limited Ordinary Shares ROEEikon Therapeutics, Inc. Common Stock operating marginYD Bio Limited Ordinary Shares operating marginEikon Therapeutics, Inc. Common Stock revenue growthYD Bio Limited Ordinary Shares revenue growthEikon Therapeutics, Inc. Common Stock free cash flowYD Bio Limited Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.